Applications are now open for the 2022 Emerging Leaders Programme – led by Senior Programme Adviser Dr Amitava Banerjee –, which will mark the eighth year of the programme and will focus on CVD and infectious diseases (e.g., COVID-19, Influenza, Chagas Disease, and Rheumatic Heart Disease). Developed by WHF Past President Professor Salim Yusuf in 2014, the programme provides training and networking opportunities in cardiovascular health policy and implementation research for healthcare practitioners, researchers, and global health advocates.
Focusing on a different priority area each year, the objective of the training module is to reduce the global burden of cardiovascular disease in line with UN Sustainable Development Goal 3.4. Our 175 strong expert community has so far tackled a number of issues, including secondary prevention of cardiovascular diseases, raised blood pressure, tobacco prevention and control, access to essential medicines, stroke, heart failure and diabetes.
The World Heart Federation aims to reach as many potential candidates as possible on a global basis. Candidates from academia, civil society, healthcare and the private sector are all encouraged to apply. Candidates may be affiliated with a member organization of the World Heart Federation, but this is not mandatory. All Emerging Leaders participants will be required to participate in online training, a five-day think tank seminar from 16-21 October 2022 in Buenos Aires, Argentina, and collaborative group work based on proposals developed during the seminar with seed funding support from WHF from meritorious applications.
The selection committee will look for candidates to demonstrate their passion for improving CVD healthcare, willingness to participate in collaborative group work, and desire for making a difference at the grassroots level and beyond.
If you are interested in applying, please visit our website.
For any further queries or information about the programme, please email emergingleaders@worldheart.org.
Applications are open until 28 February 2022.
